Stomach Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Stomach Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-12-26Clinical Trial Update: Zimberelimab + Domvanalimab in Gastroesophageal Adenocarcinoma [Phase 2]
A Phase 2 trial of zimberelimab plus domvanalimab in stomach and gastroesophageal junction adenocarcinoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-07-13Clinical Trial Update: A Study of Perioperative mFOLFOX6 Plus Pembrolizumab in Patients With Potentially Resectable Adenocarcinoma of the Gastroesophageal Junction (GEJ) and Stomach [Phase 2]
This Phase 2 trial evaluating perioperative mFOLFOX6 plus pembrolizumab for potentially resectable gastroesophageal junction and stomach ade…